血液傳染病檢查市場按產品類型、技術、檢測類型、最終用戶和地區分類

預計到 2026 年，血液傳染傳染病檢查市場價值將達到 50 億美元，到 2033 年將達到 80.25 億美元，2026 年至 2033 年的複合年成長率為 7%。

血液感染疾病是指血液中存在細菌、真菌或其他病原體感染的情況。這種情況通常發生在病原體經由傷口、注射或手術等途徑進入血液時。血液感染疾病也稱為敗血症、菌血症、敗血症或敗血性休克。由於血液感染疾病的常見症狀（如寒顫、發燒、腹瀉、嘔吐等）較多，因此難以自行診斷，必須進行檢測才能發現血液中的感染。

市場動態

感染率的上升，包括腹部感染疾病、牙科感染疾病、腎臟和尿道感染以及慢性疾病，正在推動市場成長。根據世界衛生組織（世衛組織）統計，2016年全球有超過3,000萬人感染敗血症，造成600萬人死亡。此外，血液傳染傳染病檢查研發投入的增加預計也將推動市場成長。燒燙傷和創傷、愛滋病、肺炎、腎盂腎炎和癌症的高發生率，以及衛生意識的提高，預計也將推動全球血液傳染傳染病檢查市場的成長。根據世界衛生組織（世衛組織）統計，截至2017年底，全球約有3,690萬愛滋病毒感染者，2017年新增病例估計為180萬例。然而，高昂的診斷成本和醫療報銷不足可能會限制市場成長。

本次調查的主要特點

• 本報告對血液傳染傳染病檢查市場進行了詳細分析，以 2025 年為基準年，給出了預測期（2026-2033 年）內的市場規模和複合年成長率（%）。
• 我們將重點介紹各個細分市場的潛在商機，並說明該市場具有吸引力的投資提案矩陣。
• 該研究還提供了有關市場促進因素、限制因素、機會、新產品發布或核准、市場趨勢、區域展望以及主要參與者採取的競爭策略的重要見解。
• 本報告根據以下參數介紹了全球血液傳染傳染病檢查市場主要企業的概況：公司概況、財務表現、產品系列、市場地位、分銷策略、主要發展、策略和未來計劃。
• 本報告的研究結果將使負責人和經營團隊能夠就未來的產品發布、技術升級、市場擴張和行銷策略做出明智的決策。
• 這份全球血液傳染病檢查市場報告的目標受眾是該行業的各類相關人員，包括投資者、供應商、產品製造商、經銷商、新參與企業和金融分析師。
• 相關人員可以透過各種用於分析血液傳染傳染病檢查市場的策略矩陣輕鬆做出決策。

目錄

第1章 研究目標與前提條件

• 調查目的
• 先決條件
• 簡稱

第2章 市場概覽

• 報告概述
  • 市場定義和範圍
• 執行摘要

第3章 市場動態、監管與趨勢分析

• 市場動態
• 影響分析
• 主要亮點
• 法規環境
• 產品上市及核准情況
• PEST分析
• 波特分析
• 市場機遇
• 法規環境
• 重大進展
• 產業趨勢

4. 2026-2033年全球血液傳染傳染病檢查市場（依產品類型分類）

• 裝置
• 試劑和耗材
• 其他

5. 2026-2033年全球血液傳染傳染病檢查市場（依技術分類）

• 常規測試
• 非傳統測試

6. 2026-2033年全球血液傳染傳染病檢查市場（依檢測類型分類）

• 常規血液培養檢測
• PCR方法
• 核酸檢測
• 質譜分析
• 就地檢驗

7. 2026-2033年全球血液傳染傳染病檢查市場（依最終用戶分類）

• 醫院
• 獨立診斷中心
• 其他

8. 2026-2033年全球血液傳染傳染病檢查市場（按地區分類）

• 北美洲
  • 美國
  • 加拿大
• 拉丁美洲
  • 巴西
  • 阿根廷
  • 墨西哥
  • 其他拉丁美洲國家
• 歐洲
  • 德國
  • 英國
  • 西班牙
  • 法國
  • 義大利
  • 俄羅斯
  • 其他歐洲
• 亞太地區
  • 中國
  • 印度
  • 日本
  • 澳洲
  • 韓國
  • ASEAN
  • 亞太其他地區
• 中東
  • 海灣合作理事會國家
  • 以色列
  • 其他中東國家
• 非洲
  • 南非
  • 北非
  • 中非

第9章 競爭情勢

• BioMerieux SA
• Becton
• Dickinson and Company
• AB Sciex
• IRIDICA
• Abbot Laboratories
• Cepheid Inc.
• CR Bard, Inc.
• F. Hoffmann-La Roche AG
• Nanoshpere
• Dade Behring
• AdvanDX
• Siemens Healthcare

第10章 分析師建議

• 機會
• 分析師觀點
• Coherent Opportunity Map

第11章 參考文獻與調查方法

• 參考
• 調查方法
• 關於本公司

Bloodstream Infection Testing Market is estimated to be valued at USD 5,000 Mn in 2026 and is expected to reach USD 8,025 Mn by 2033, growing at a compound annual growth rate (CAGR) of 7% from 2026 to 2033.

Blood stream infection is a condition in which the blood is detected with bacterial, fungal, or any other infection. This condition normally occurs when the infection enters the blood stream of any part of body through wound, injection or during any surgical procedures. This infection is also considered as blood poisoning, bacteremia, septicemia, or sepsis. Self-diagnosis of blood stream infections is difficult, owing to its common symptoms (such as chills, fever, diarrhea, vomiting, and others), thereby testing is mandatory for detection of infections in blood.

Market Dynamics

Increasing prevalence of infections such as abdominal infections, dental infections, kidney and urinary infection, and chronic diseases drives the market growth. According to the World Health Organization (WHO), in 2016, over 30 million people are affected by sepsis worldwide, annually, leading to 6 million deaths. Moreover, increasing R&D investments related to bloodstream infection testing is also expected to boost the market growth. Moreover, high incidences of burns/wounds cases, HIV, pneumonia, pyelonephritis, and cancer along with growing awareness about hygiene is also expected to boost the global bloodstream infection testing market growth. According to World Health Organization, at the end of 2017, approximately 36.9 million people living with HIV and 1.8 million people becoming newly ininfected in 2017 globally. However, the high diagnostic costs and insufficiency medical reimbursement may hinder the market growth.

Key features of the study

• This report provides in-depth analysis of the bloodstream infection testing market and provides market size (USD Mn) and Compound Annual Growth Rate (CAGR %) for the forecast period (2026 - 2033), considering 2025 as the base year
• It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
• This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players
• It profiles key players in the global bloodstream infection testing market based on the following parameters - company overview, financial performance, product portfolio, market presence, distribution strategies, key developments, strategies, and future plans.
• Key companies covered as a part of this study include, BioMerieux SA, Becton, Dickinson and Company, AB Sciex, IRIDICA, Abbot Laboratories, Cepheid Inc., C. R. Bard, Inc., F. Hoffmann-La Roche AG, Nanoshpere, Dade Behring, AdvanDX, Siemens Healthcare.
• Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, technology up-gradation, market expansion, and marketing tactics
• The global bloodstream infection testing market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
• Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the bloodstream infection testing market

Market Segmentation

• Product Type Insights (Revenue, USD Mn, 2026 - 2033)
  • Instruments
  • Reagents & Consumables
  • Others
• Technology Insights (Revenue, USD Mn, 2026 - 2033)
  • Conventional Testing
  • Non-Conventional Testing
• Test Type Insights (Revenue, USD Mn, 2026 - 2033)
  • Conventional Blood Culture Tests
  • PCR Method
  • Nucleic Acid Testing
  • Mass Spectroscopy
  • Point-Of-Care Testing
• End User Insights (Revenue, USD Mn, 2026 - 2033)
  • Hospitals
  • Independent Diagnostics Centers
  • Others
• Regional Insights (Revenue, USD Mn, 2026 - 2033)
  • North America
  • U.S.
  • Canada
  • Latin America
  • Brazil
  • Argentina
  • Mexico
  • Rest of Latin America
  • Europe
  • Germany
  • U.K.
  • France
  • Italy
  • Russia
  • Rest of Europe
  • Asia Pacific
  • China
  • India
  • Japan
  • Australia
  • South Korea
  • ASEAN
  • Rest of Asia Pacific
  • Middle East
  • GCC
  • Israel
  • Rest of Middle East
  • Africa
  • North Africa
  • Central Africa
  • South Africa
• Key Players Insights
  • BioMerieux SA
  • Becton
  • Dickinson and Company
  • AB Sciex
  • IRIDICA
  • Abbot Laboratories
  • Cepheid Inc.
  • C. R. Bard, Inc.
  • F. Hoffmann-La Roche AG
  • Nanoshpere
  • Dade Behring
  • AdvanDX
  • Siemens Healthcare

Table of Contents

1. Research Objectives and Assumptions

• Research Objectives
• Assumptions
• Abbreviations

2. Market Overview

• Report Description
  • Market Definition and Scope
• Executive Summary
  • Global Bloodstream Infection Testing Market, By Product Type
  • Global Bloodstream Infection Testing Market, By Technology
  • Global Bloodstream Infection Testing Market, By Test Type
  • Global Bloodstream Infection Testing Market, By End User
  • Global Bloodstream Infection Testing Market, By Region

3. Market Dynamics, Regulations, and Trends Analysis

• Market Dynamics
• Impact Analysis
• Key Highlights
• Regulatory Scenario
• Product Launches/Approvals
• PEST Analysis
• PORTER's Analysis
• Market Opportunities
• Regulatory Scenario
• Key Developments
• Industry Trend

4. Global Bloodstream Infection Testing Market, By Product Type, 2026-2033, (USD Mn)

• Introduction
  • Market Share Analysis, 2026 and 2033 (%)
  • Y-o-Y Growth Analysis, 2021 - 2033
  • Segment Trends
• Instruments
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2026-2033, (USD Mn)
• Reagents & Consumables
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2026-2033, (USD Mn)
• Others
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2026-2033, (USD Mn)

5. Global Bloodstream Infection Testing Market, By Technology, 2026-2033, (USD Mn)

• Introduction
  • Market Share Analysis, 2026 and 2033 (%)
  • Y-o-Y Growth Analysis, 2021 - 2033
  • Segment Trends
• Conventional Testing
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2026-2033, (USD Mn)
• Non-Conventional Testing
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2026-2033, (USD Mn)

6. Global Bloodstream Infection Testing Market, By Test Type, 2026-2033, (USD Mn)

• Introduction
  • Market Share Analysis, 2026 and 2033 (%)
  • Y-o-Y Growth Analysis, 2021 - 2033
  • Segment Trends
• Conventional Blood Culture Tests
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2026-2033, (USD Mn)
• PCR Method
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2026-2033, (USD Mn)
• Nucleic Acid Testing
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2026-2033, (USD Mn)
• Mass Spectroscopy
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2026-2033, (USD Mn)
• Point-Of-Care Testing
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2026-2033, (USD Mn)

7. Global Bloodstream Infection Testing Market, By End User, 2026-2033, (USD Mn)

• Introduction
  • Market Share Analysis, 2026 and 2033 (%)
  • Y-o-Y Growth Analysis, 2021 - 2033
  • Segment Trends
• Hospitals
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2026-2033, (USD Mn)
• Independent Diagnostics Centers
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2026-2033, (USD Mn)
• Others
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2026-2033, (USD Mn)

8. Global Bloodstream Infection Testing Market, By Region, 2026 - 2033, Value (USD Mn)

• Introduction
  • Market Share (%) Analysis, 2026, 2028 & 2033, Value (USD Mn)
  • Market Y-o-Y Growth Analysis (%), 2021 - 2033, Value (USD Mn)
  • Regional Trends
• North America
  • Introduction
  • Market Size and Forecast, By Product Type, 2026 - 2033, Value (USD Mn)
  • Market Size and Forecast, By Technology, 2026 - 2033, Value (USD Mn)
  • Market Size and Forecast, By Test Type, 2026 - 2033, Value (USD Mn)
  • Market Size and Forecast, By End User, 2026 - 2033, Value (USD Mn)
  • Market Size and Forecast, By Country, 2026 - 2033, Value (USD Mn)
    • U.S.
    • Canada
• Latin America
  • Introduction
  • Market Size and Forecast, By Product Type, 2026 - 2033, Value (USD Mn)
  • Market Size and Forecast, By Technology, 2026 - 2033, Value (USD Mn)
  • Market Size and Forecast, By Test Type, 2026 - 2033, Value (USD Mn)
  • Market Size and Forecast, By End User, 2026 - 2033, Value (USD Mn)
  • Market Size and Forecast, By Country, 2026 - 2033, Value (USD Mn)
    • Brazil
    • Argentina
    • Mexico
    • Rest of Latin America
• Europe
  • Introduction
  • Market Size and Forecast, By Product Type, 2026 - 2033, Value (USD Mn)
  • Market Size and Forecast, By Technology, 2026 - 2033, Value (USD Mn)
  • Market Size and Forecast, By Test Type, 2026 - 2033, Value (USD Mn)
  • Market Size and Forecast, By End User, 2026 - 2033, Value (USD Mn)
  • Market Size and Forecast, By Country, 2026 - 2033, Value (USD Mn)
    • Germany
    • U.K.
    • Spain
    • France
    • Italy
    • Russia
    • Rest of Europe
• Asia Pacific
  • Introduction
  • Market Size and Forecast, By Product Type, 2026 - 2033, Value (USD Mn)
  • Market Size and Forecast, By Technology, 2026 - 2033, Value (USD Mn)
  • Market Size and Forecast, By Test Type, 2026 - 2033, Value (USD Mn)
  • Market Size and Forecast, By End User, 2026 - 2033, Value (USD Mn)
  • Market Size and Forecast, By Country, 2026 - 2033, Value (USD Mn)
    • China
    • India
    • Japan
    • Australia
    • South Korea
    • ASEAN
    • Rest of Asia Pacific
• Middle East
  • Introduction
  • Market Size and Forecast, By Product Type, 2026 - 2033, Value (USD Mn)
  • Market Size and Forecast, By Technology, 2026 - 2033, Value (USD Mn)
  • Market Size and Forecast, By Test Type, 2026 - 2033, Value (USD Mn)
  • Market Size and Forecast, By End User, 2026 - 2033, Value (USD Mn)
  • Market Size and Forecast, By Country, 2026 - 2033, Value (USD Mn)
    • GCC Countries
    • Israel
    • Rest of Middle East
• Africa
  • Introduction
  • Market Size and Forecast, By Product Type, 2026 - 2033, Value (USD Mn)
  • Market Size and Forecast, By Technology, 2026 - 2033, Value (USD Mn)
  • Market Size and Forecast, By Test Type, 2026 - 2033, Value (USD Mn)
  • Market Size and Forecast, By End User, 2026 - 2033, Value (USD Mn)
  • Market Size and Forecast, By Country, 2026 - 2033, Value (USD Mn)
    • South Africa
    • North Africa
    • Central Africa

9. Competitive Landscape

• BioMerieux SA
  • Company Highlights
  • Product Portfolio
  • Key Developments
  • Financial Performance
  • Strategies
• Becton
  • Company Highlights
  • Product Portfolio
  • Key Developments
  • Financial Performance
  • Strategies
• Dickinson and Company
  • Company Highlights
  • Product Portfolio
  • Key Developments
  • Financial Performance
  • Strategies
• AB Sciex
  • Company Highlights
  • Product Portfolio
  • Key Developments
  • Financial Performance
  • Strategies
• IRIDICA
  • Company Highlights
  • Product Portfolio
  • Key Developments
  • Financial Performance
  • Strategies
• Abbot Laboratories
  • Company Highlights
  • Product Portfolio
  • Key Developments
  • Financial Performance
  • Strategies
• Cepheid Inc.
  • Company Highlights
  • Product Portfolio
  • Key Developments
  • Financial Performance
  • Strategies
• C. R. Bard, Inc.
  • Company Highlights
  • Product Portfolio
  • Key Developments
  • Financial Performance
  • Strategies
• F. Hoffmann-La Roche AG
  • Company Highlights
  • Product Portfolio
  • Key Developments
  • Financial Performance
  • Strategies
• Nanoshpere
  • Company Highlights
  • Product Portfolio
  • Key Developments
  • Financial Performance
  • Strategies
• Dade Behring
  • Company Highlights
  • Product Portfolio
  • Key Developments
  • Financial Performance
  • Strategies
• AdvanDX
  • Company Highlights
  • Product Portfolio
  • Key Developments
  • Financial Performance
  • Strategies
• Siemens Healthcare
  • Company Highlights
  • Product Portfolio
  • Key Developments
  • Financial Performance
  • Strategies

10. Analyst Recommendations

• Wheel of Fortune
• Analyst View
• Coherent Opportunity Map

11. References and Research Methodology

• References
• Research Methodology
• About us